Brokerages Anticipate AbbVie Inc (ABBV) to Announce $1.40 EPS

On Thursday, May 18 CHASE WILLIAM J sold $2.50M worth of AbbVie Inc (NYSE:ABBV) or 38,300 shares. The shares were sold at an average price of $70.09, for a total value of $1,261,620.00.

The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. (ABBV) traded up 0.32% during midday trading on Tuesday, reaching $91.07. Investec Asset Management LTD lifted its holdings in shares of AbbVie by 3.6% during the 1st quarter. Old Republic Intll invested 0.99% in AbbVie Inc (NYSE:ABBV). It has underperformed by 6.07% the S&P500.

The stock of Ebix Inc (NASDAQ:EBIX) hit a new 52-week high and has $72.49 target or 9.00% above today's $66.50 share price. The Weekly and Monthly Volatility stands at 1.40% and 2.01%.'s article titled: "Workday Delivers Deeper Insights to Business Leaders with Workday Prism Analytics" and published on October 10, 2017 is yet another important article. Consensus earnings estimates are far from ideal, but they are watched by many investors and play an important role in measuring the appropriate valuation for a stock.

About 583,984 shares traded. AbbVie Inc (NYSE:ABBV) has risen 10.63% since October 9, 2016 and is uptrending. It has outperformed by 5.25% the S&P500.

09/25/2017 - AbbVie Inc. was downgraded to "neutral" by analysts at UBS. They are also projecting the Low EPS estimate of $1.36 and the High EPS estimate of $1.58. It has a 61.94 P/E ratio.

Ebix, a supplier of software and e-commerce solutions to the insurance industry. The company has market cap of $143.25 billion. Ebix provides application software products for the insurance industry, including carrier systems, agency systems and exchanges, as well as custom software development.

Since June 12, 2017, it had 1 insider purchase, and 0 insider sales for $299,371 activity. As per Monday, May 29, the company rating was maintained by Jefferies. The company reported $1.42 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.40 by $0.02. Similarly, the company's SVP, Operations SALEKI-GERHARDT AZITA on 2017-09-11 Sell 8300 shares of the company at a price of $85.02. 19 funds opened positions while 63 raised stakes. Asset One Communication Limited invested in 0.48% or 2.61M shares. Federated Inc Pa stated it has 0.37% of its portfolio in Workday Inc (NASDAQ:WDAY). Mufg Americas Holdings has 55,490 shares for 0.13% of their portfolio. Cornerstone Advsr Inc stated it has 0% of its portfolio in Workday Inc (NASDAQ:WDAY). Price T Rowe Assocs Incorporated Md has 0% invested in NN, Inc. State Of New Jersey Common Pension Fund D holds 0.04% or 296,500 shares in its portfolio.

Summit Financial Wealth Advisors Llc decreased Ford Mtr Co Del (NYSE:F) stake by 206,317 shares to 26,711 valued at $299,000 in 2017Q2. Hall Laurie J Trustee holds 0% or 52,195 shares. Raymond James Fincl Advisors stated it has 155,440 shares.

In related news, insider Henry O. Gosebruch sold 18,000 shares of the company's stock in a transaction on Monday, July 31st. Shares for $5.59 million were sold by Schumacher Laura J on Wednesday, June 14. 23,977 shares were sold by PEEK MARK S, worth $2.47M.

Sfe Investment Counsel, which manages about $321.20 million and $246.25 million US Long portfolio, upped its stake in First Rep Bk San Francisco C (NYSE:FRC) by 5,405 shares to 25,280 shares, valued at $2.53 million in 2017Q2, according to the filing. Also, VP Robert A. Michael sold 6,699 shares of the company's stock in a transaction on Thursday, September 28th. Atwood & Palmer Inc. increased its stake in AbbVie by 1,333.3% in the first quarter. Its up 0.01, from 0.99 in 2017Q1.

AbbVie Inc. has its outstanding Shares of 1.6 Billion. First Command Financial Services Inc. raised its stake in AbbVie by 6.8% in the first quarter. AllSquare Wealth Management LLC now owns 2,104 shares of the company's stock worth $137,000 after buying an additional 454 shares during the period. Raymond James initiated AbbVie Inc (NYSE:ABBV) rating on Friday, September 2. Atwood & Palmer Inc. now owns 2,150 shares of the company's stock valued at $140,000 after acquiring an additional 2,000 shares during the period. GONZALEZ RICHARD A also sold $4.67M worth of AbbVie Inc (NYSE:ABBV) shares. Ami Asset Management Corp, a California-based fund reported 1.00 million shares. 10,769 were reported by Arrow Corp. 698 are owned by Inr Advisory Llc.

Media headlines about AbbVie (NYSE:ABBV) have been trending somewhat positive on Sunday, according to Accern Sentiment Analysis. Massachusetts-based Anchor Advisors Limited Liability Com has invested 0.02% in AbbVie Inc (NYSE:ABBV).

COPYRIGHT VIOLATION NOTICE: "AbbVie (ABBV) Given News Sentiment Rating of 0.14" was originally posted by BBNS and is the property of of BBNS. AQR Capital Management LLC now owns 940,824 shares of the company's stock worth $61,304,000 after buying an additional 347,710 shares in the last quarter.

The Pennsylvania-based Univest Of Pennsylvania has invested 1.79% in AbbVie Inc (NYSE:ABBV). Therefore 48% are positive.

Many analysts have provided their estimated foresights on AbbVie Inc. Leerink Swann initiated AbbVie Inc (NYSE:ABBV) rating on Tuesday, October 18.

Evercore ISI Group initiated coverage on ABBV giving it an initial rating of "Outperform". The stock's market capitalization is 144.71B. The company was maintained on Wednesday, April 19 by BMO Capital Markets. Jefferies Group LLC reissued a "buy" rating and issued a $107.00 target price (up previously from $94.00) on shares of AbbVie in a research note on Friday, September 15th. The firm has "Neutral" rating by Citigroup given on Monday, November 28.

12/07/2016 - AbbVie Inc. had its "outperform" rating reiterated by analysts at William Blair.

Latest News